The staining of a BC tumor microarray (TMA) with 119 different samples revealed that the majority of the tumor samples expressed moderate levels of EZH2 and high levels of NFATc1 (Fig. 5C left panel and Fig. S5G). This evidence concerns the gene EZH2 and breast cancer.